DiaSorin Past Earnings Performance

Past criteria checks 2/6

DiaSorin has been growing earnings at an average annual rate of 5.2%, while the Medical Equipment industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 15.7% per year. DiaSorin's return on equity is 10.3%, and it has net margins of 13.9%.

Key information

5.2%

Earnings growth rate

4.1%

EPS growth rate

Medical Equipment Industry Growth8.3%
Revenue growth rate15.7%
Return on equity10.3%
Net Margin13.9%
Next Earnings Update10 May 2024

Recent past performance updates

Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

Nov 11
Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

Recent updates

DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

Apr 09
DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

Mar 25
DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Mar 20
DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 17
DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Is DiaSorin (BIT:DIA) Using Too Much Debt?

Jan 25
Is DiaSorin (BIT:DIA) Using Too Much Debt?

Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

Nov 11
Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 24% Below Its Share Price

Oct 11
DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 24% Below Its Share Price

Is DiaSorin (BIT:DIA) A Risky Investment?

Sep 19
Is DiaSorin (BIT:DIA) A Risky Investment?

Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

May 01
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10

Apr 02
DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10

Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

Jan 07
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

These 4 Measures Indicate That DiaSorin (BIT:DIA) Is Using Debt Reasonably Well

Sep 13
These 4 Measures Indicate That DiaSorin (BIT:DIA) Is Using Debt Reasonably Well

Are DiaSorin S.p.A. (BIT:DIA) Investors Paying Above The Intrinsic Value?

Aug 17
Are DiaSorin S.p.A. (BIT:DIA) Investors Paying Above The Intrinsic Value?

DiaSorin (BIT:DIA) Has A Pretty Healthy Balance Sheet

Jun 14
DiaSorin (BIT:DIA) Has A Pretty Healthy Balance Sheet

DiaSorin (BIT:DIA) Will Pay A Larger Dividend Than Last Year At €1.05

May 19
DiaSorin (BIT:DIA) Will Pay A Larger Dividend Than Last Year At €1.05

DiaSorin's (BIT:DIA) Shareholders Will Receive A Bigger Dividend Than Last Year

May 03
DiaSorin's (BIT:DIA) Shareholders Will Receive A Bigger Dividend Than Last Year

Calculating The Fair Value Of DiaSorin S.p.A. (BIT:DIA)

May 01
Calculating The Fair Value Of DiaSorin S.p.A. (BIT:DIA)

DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

Apr 13
DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.05

Mar 21
DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.05

Here's Why I Think DiaSorin (BIT:DIA) Is An Interesting Stock

Mar 02
Here's Why I Think DiaSorin (BIT:DIA) Is An Interesting Stock

Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 19
Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value

Is DiaSorin (BIT:DIA) Using Too Much Debt?

Dec 04
Is DiaSorin (BIT:DIA) Using Too Much Debt?

Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Oct 18
Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Is DiaSorin (BIT:DIA) A Risky Investment?

Aug 23
Is DiaSorin (BIT:DIA) A Risky Investment?

Industry Analysts Just Upgraded Their DiaSorin S.p.A. (BIT:DIA) Revenue Forecasts By 12%

Jul 15
Industry Analysts Just Upgraded Their DiaSorin S.p.A. (BIT:DIA) Revenue Forecasts By 12%

Here's Why I Think DiaSorin (BIT:DIA) Might Deserve Your Attention Today

Jul 13
Here's Why I Think DiaSorin (BIT:DIA) Might Deserve Your Attention Today

Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Apr 02
Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

DiaSorin S.p.A.'s (BIT:DIA) 0.7% Dividend Yield Looks Pretty Interesting

Mar 15
DiaSorin S.p.A.'s (BIT:DIA) 0.7% Dividend Yield Looks Pretty Interesting

Are Institutions Heavily Invested In DiaSorin S.p.A.'s (BIT:DIA) Shares?

Feb 25
Are Institutions Heavily Invested In DiaSorin S.p.A.'s (BIT:DIA) Shares?

Returns On Capital - An Important Metric For DiaSorin (BIT:DIA)

Feb 04
Returns On Capital - An Important Metric For DiaSorin (BIT:DIA)

Did You Participate In Any Of DiaSorin's (BIT:DIA) Incredible 311% Return?

Jan 14
Did You Participate In Any Of DiaSorin's (BIT:DIA) Incredible 311% Return?

Is Now The Time To Put DiaSorin (BIT:DIA) On Your Watchlist?

Dec 24
Is Now The Time To Put DiaSorin (BIT:DIA) On Your Watchlist?

Are Robust Financials Driving The Recent Rally In DiaSorin S.p.A.'s (BIT:DIA) Stock?

Dec 02
Are Robust Financials Driving The Recent Rally In DiaSorin S.p.A.'s (BIT:DIA) Stock?

Revenue & Expenses Breakdown
Beta

How DiaSorin makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BIT:DIA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,14816041491
30 Sep 231,19515041493
30 Jun 231,25218842097
31 Mar 231,29320042098
31 Dec 221,36124141597
30 Sep 221,39128541097
30 Jun 221,40830239193
31 Mar 221,32931534680
31 Dec 211,23831130570
30 Sep 211,13031525857
30 Jun 211,01430322349
31 Mar 2197328821951
31 Dec 2088124821751
30 Sep 2079121221352
30 Jun 2073818621450
31 Mar 2071017321449
31 Dec 1970617621348
30 Sep 1970016821246
30 Jun 1968816120946
31 Mar 1967516020645
31 Dec 1866915820145
30 Sep 1866316119745
30 Jun 1864915419244
31 Mar 1864414518945
31 Dec 1763714018844
30 Sep 1762512518543
30 Jun 1762212518343
31 Mar 1760212117841
31 Dec 1656911217038
30 Sep 1654411116434
30 Jun 1652010615830
31 Mar 1650610215527
31 Dec 1549910015426
30 Sep 154869515125
30 Jun 154729314825
31 Mar 154558714425
31 Dec 144448414025
30 Sep 144378413925
30 Jun 144328213724
31 Mar 144358213724
31 Dec 134358313624
30 Sep 134338213424
30 Jun 134338313424

Quality Earnings: DIA has high quality earnings.

Growing Profit Margin: DIA's current net profit margins (13.9%) are lower than last year (17.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DIA's earnings have grown by 5.2% per year over the past 5 years.

Accelerating Growth: DIA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DIA had negative earnings growth (-33.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-18.4%).


Return on Equity

High ROE: DIA's Return on Equity (10.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.